The AllCells Blog

AllCells Blog

AllCells blog posts are dedicated to highlighting scientific trends, innovation, and technological advances within the biomedical industry. Data-driven studies and primary research are conducted to create our blogs and include experts within the following fields: immuno-oncologists, cell and gene therapy, academia, government, and contract research organizations.
AllCells clinical grade bone marrow stem cells

Clinical Applications of Bone Marrow-Derived Mesenchymal Stem Cells

June 17, 2021

While next generation cell-based treatments like CAR-T immunotherapies have been the source of much excitement and clinical investment in recent years, cellular therapies have a long, established history in the […]

red and white blood cells

FAQ Series: What is the difference between Buffy Coat and Leukapheresis?

June 2, 2021

Welcome to the first installment of the FAQ series here on the AllCells blog where we will answer some key questions relating to hematological tissue products. Today, we will unpack […]

AllCells Good Manufacturing Practices Facilitates Good Products

Good Manufacturing Practices (GMP) Facilitates Good Products

May 7, 2021

With the FDA approvals of several cell therapy products (Kymriah® and Yescarta®) and many more cell therapies progressing towards clinical trials, sourcing high-quality cellular materials has become a critical determinant […]

Natural Killer (NK) cells for cancer immunotherapy

Harnessing the Power of Natural Killer Cells for Cancer Immunotherapy

April 14, 2021

The immune system is our body’s biological defense system against a variety of pathogens and is separated into the innate and adaptive branches. Our innate immune system is the body’s […]

CD14+ monocytes leukocytes white blood cells

CD14+ Monocytes are a Critical Component of the Innate Immune System

February 22, 2021

What are Monocytes? Hematopoietic stem cells (HSCs), which reside in the bone marrow give rise to blood cells in a process called hematopoiesis. HSCs differentiate into the lymphoid and myeloid […]

PBMCs: A powerful research tool

October 28, 2020

What are PBMCs? Human peripheral blood mononuclear cells (PBMCs) are key components of the body’s complex and dynamic immune system. A mononuclear cell is characterized by a single round nucleus […]


Maintain Flexibility in your Workflow without Compromising Quality – Cryopreserved Leukopaks

September 15, 2020

Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks […]


AllCells Announces Expanded Product Portfolio, Guaranteed Cell-Count Leukopaks

August 17, 2020

Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its […]


Chimeric Antigen Receptor (CAR) T-Cell Therapy

July 20, 2020

Re-tasking our body’s own immune system to treat cancer has been a major scientific goal over the last few decades. According to the National Cancer Institute, it is estimated that […]

mobilized peripheral blood

Mobilized Peripheral Blood: Maximize Your CD34+ Yield

July 8, 2020

Hematopoietic stem and progenitor cells (HSPCs) are primarily found in the bone marrow, which is the main site of hematopoiesis in humans. The CD34 marker is most commonly associated with […]

Subscribe to Our Blog

Stay current with the AllCells Blog. Get email updates with helpful resources for biomedical researchers:

Customer Service

How Can We Help You?

Looking for research tips? Need help sourcing materials? How about a few more articles on therapies or processes? At AllCells, we believe that partnerships create the best pathways to success. Our Customer Success Team has years of industry experience and a wealth of resources to help you get the most out of your cellular products. We’re only a few clicks away.

Contact Us
Have a question? Let’s chat.